Amisulpride, classified with the atypical antipsychotics, is indicated for the treatment of schizophrenic disorders.
Unipharm’s generic Amisulpride Tablets have been manufactured and marketed in Israel since 2016.
ATC4: N05AL
Strengths: 100 & 400 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect
